Posted by Michael Wonder on 03 Jan 2025
Population health impact of new drugs recommended by NICE in England during 2000–20: a retrospective analysis
4 January 2025 - Health systems experience difficult trade-offs when paying for new drugs. In England, funding recommendations by NICE for new drugs might generate health gains, but inevitably result in forgone health as the funds cannot be used for alternative treatments and services.
We aimed to evaluate the population health impact of NICE recommendations for new drugs during 2000–20.
